Mechanism of Action
Membrane Carpet Mechanism
Tyrocidine A adopts a beta-sheet conformation that lies parallel to the membrane surface. At threshold concentrations, it covers the membrane like a carpet, causing disruption of bilayer integrity without forming discrete pores. This leads to membrane permeabilization, loss of ion gradients, and cell death. The mechanism differs from barrel-stave or toroidal pore AMPs.
DNA Binding
At intracellular concentrations, tyrocidine binds to DNA and inhibits transcription. This secondary mechanism may contribute to its bactericidal activity after membrane disruption allows intracellular accumulation. The DNA-binding activity also underlies its cytotoxicity to eukaryotic cells at antibacterial concentrations.
Research Summary
Historical Antibiotic Use
PreclinicalTyrothricin (containing tyrocidine and gramicidin) was one of the first clinically used antibiotics, introduced in the 1940s for topical treatment of wound infections. While systemic use was precluded by hemolytic toxicity, topical formulations remained in clinical use in some countries for decades.
Non-Ribosomal Biosynthesis
PreclinicalTyrocidine is synthesized by a multi-enzyme non-ribosomal peptide synthetase (NRPS) complex in B. brevis. Detailed understanding of the tyrocidine NRPS has made it a model system for studying cyclic peptide biosynthesis and bioengineering. Combinatorial biosynthesis approaches have generated tyrocidine analogs with altered spectra.
Calculate your Tyrocidine dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| In vitro MIC | 1-8 mcg/mL | Single | Broth assay |
| Membrane disruption model | 5-20 mcg/mL | Single | Liposome assay |
Tyrocidine is toxic to eukaryotic cells at antibacterial concentrations. Research use only.
Interactions
Safety Profile
Tyrocidine A is hemolytic and cytotoxic to mammalian cells at concentrations required for antibacterial activity, precluding systemic use. Topical applications were historically tolerated at low concentrations. Its dual DNA-binding and membrane-disrupting activities make resistance development difficult but also limit therapeutic selectivity.
References
- [1]Mootz HD et al. (2002). The tyrocidine biosynthesis operon of Bacillus brevis: complete nucleotide sequence and biochemical characterization of functional internal adenylation domain-peptidyl carrier protein communication. Journal of Bacteriology, 184(5), 1432-1438.
- [2]Rautenbach M et al. (2007). Inhibition of tyrocidine biosynthesis by myxalamid, an antifungal polyene antibiotic from Myxococcus xanthus. Biochemistry, 46(3), 903-910.